New Welsh Fund Will Give Quicker Access To New Drugs Than In England Or Scotland
A new fund is expected to help remove uncertainties around the financing of new treatments in the future. It introduces new timelines for health boards to ensure that innovative medicines approved by NICE or the Welsh AWMSG are made available faster to eligible patients on the NHS.
You may also be interested in...
UK proposals to promote innovation and speed access to promising new drugs could among other things prompt new payment models. The final report on the government’s Accelerated Access Review should be out by the end of the month.
New treatments for advanced endometrial cancer and hereditary angioedema are among six drugs that have just been recommended for EU-wide approval. Harmonized EU advice has also been issued in relation to an investigational antibody combination for treating COVID-19.
As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.